Comparison of Top Two Shares of the Day: Xcel Energy Inc. (NASDAQ:XEL), Seattle Genetics, Inc. (NASDAQ:SGEN)

Xcel Energy Inc. (NASDAQ:XEL)

Xcel Energy Inc. (NASDAQ:XEL) closed at $57.22 on the last trading session with an decrease of -0.16%, whereas, it previously closed at $57.31. The company has a market capitalization of $29.47 Billion. The company traded shares of 2.95 Million on the trading day while its three month average volume stands at 3.18 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Xcel Energy Inc. (NASDAQ:XEL) produced diluted EPS of 1.96. The EPS estimate for next year as estimated by analysts is at 2.79 while EPS for next quarter is estimated at 0.55. Earnings per Share growth for this year is reported at -22.8, while the analysts estimated the EPS growth for next year at 2.79% and Earnings growth for next 5 years stands at 6.25% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -1.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Xcel Energy Inc. (NASDAQ:XEL) is at 29.16 while the forward p/e is at 20.51. The P/S or Price to Sales ratio of Xcel Energy Inc. (NASDAQ:XEL) stands at 2.51 and Price to Book or P/B for the most recent quarter stands at 2.39. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Xcel Energy Inc. (NASDAQ:XEL) are reported at 0.6 and 0.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Xcel Energy Inc. (NASDAQ:XEL) stands at 2.8, 10.6 and 4.9 respectively

The trailing twelve month Revenue of Xcel Energy Inc. (NASDAQ:XEL) is reported at 11.73 Billion with income of 1.01 Billion. The outstanding shares of Xcel Energy Inc. (NASDAQ:XEL) are 515 Million. The institutional Ownership of the shares of 78.2 stands at 0.80%, this figure is increased 0.78 in the last six months. The insider ownership for the shares of Xcel Energy Inc. (NASDAQ:XEL) is ticked at 0.2%, the figure is plummeted -8.28% in the last six months.

Some other important financial aspects to be discussed here for Xcel Energy Inc. (NASDAQ:XEL) is the Mean Target Price estimated by the analysts which stands at 56.5. The 52 week high of Xcel Energy Inc. (NASDAQ:XEL) is placed at 57.85 and 52 week low is standing at 41.99.

Performance wise the shares of Xcel Energy Inc. (NASDAQ:XEL) rose up 2.4% for the week, it also rise 2.58% for the monthly performance, while for the quarter it went down 7.42%. The shares increase 13.67% for the half year and flew up for the Year-To-Date performance. The shares of Xcel Energy Inc. (NASDAQ:XEL) grew 27.13% for the yearly performance.

Seattle Genetics, Inc. (NASDAQ:SGEN)

Seattle Genetics, Inc. (NASDAQ:SGEN) closed at $63.99 on the last trading session with an increase of 0.05%, whereas, it previously closed at $63.96. The company has a market capitalization of $10.36 Billion. The company traded shares of 488164 on the trading day while its three month average volume stands at 823.32 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Seattle Genetics, Inc. (NASDAQ:SGEN) produced diluted EPS of -0.79. The EPS estimate for next year as estimated by analysts is at -0.4 while EPS for next quarter is estimated at -0.39. Earnings per Share growth for this year is reported at -61.1, while the analysts estimated the EPS growth for next year at -0.4% and Earnings growth for next 5 years stands at 23% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -22.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Seattle Genetics, Inc. (NASDAQ:SGEN) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Seattle Genetics, Inc. (NASDAQ:SGEN) stands at 14.6 and Price to Book or P/B for the most recent quarter stands at 7.82. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Seattle Genetics, Inc. (NASDAQ:SGEN) are reported at 2.9 and 3.3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Seattle Genetics, Inc. (NASDAQ:SGEN) stands at -8, -9.3 and -18.6 respectively

The trailing twelve month Revenue of Seattle Genetics, Inc. (NASDAQ:SGEN) is reported at 709.3 Million with income of -124300000. The outstanding shares of Seattle Genetics, Inc. (NASDAQ:SGEN) are 161.84 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 0.46 in the last six months. The insider ownership for the shares of Seattle Genetics, Inc. (NASDAQ:SGEN) is ticked at 0.9%, the figure is plummeted -10.87% in the last six months.

Some other important financial aspects to be discussed here for Seattle Genetics, Inc. (NASDAQ:SGEN) is the Mean Target Price estimated by the analysts which stands at 79.46. The 52 week high of Seattle Genetics, Inc. (NASDAQ:SGEN) is placed at 84.37 and 52 week low is standing at 50.71.

Performance wise the shares of Seattle Genetics, Inc. (NASDAQ:SGEN) fell down -6.12% for the week, it also fell -17.58% for the monthly performance, while for the quarter it went up -6.32%. The shares increase 10.21% for the half year and flew up for the Year-To-Date performance. The shares of Seattle Genetics, Inc. (NASDAQ:SGEN) grew 11.13% for the yearly performance.